| Number of Patients, Male | 6 |
| Number of Patients, Female | 1 |
| Stage | Metastatic, 6 |
| Age | Median (range): 65 (48–78) years |
| Number of Prior Systemic Therapies | Median: null |
| Performance Status: ECOG | 0 — 1 1 — 6 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes | Squamous cell carcinoma of head and neck, 4 Gastric/gastroesophageal adenocarcinoma, 1 Non-small cell lung cancer, 1 Urothelial cancer, 1 |
| Number of Patients, Male | 6 |
| Number of Patients, Female | 1 |
| Stage | Metastatic, 6 |
| Age | Median (range): 65 (48–78) years |
| Number of Prior Systemic Therapies | Median: null |
| Performance Status: ECOG | 0 — 1 1 — 6 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes | Squamous cell carcinoma of head and neck, 4 Gastric/gastroesophageal adenocarcinoma, 1 Non-small cell lung cancer, 1 Urothelial cancer, 1 |
| Number of Patients, Male | 6 |
| Number of Patients, Female | 1 |
| Stage | Metastatic, 6 |
| Age | Median (range): 65 (48–78) years |
| Number of Prior Systemic Therapies | Median: null |
| Performance Status: ECOG | 0 — 1 1 — 6 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes | Squamous cell carcinoma of head and neck, 4 Gastric/gastroesophageal adenocarcinoma, 1 Non-small cell lung cancer, 1 Urothelial cancer, 1 |
| Number of Patients, Male | 6 |
| Number of Patients, Female | 1 |
| Stage | Metastatic, 6 |
| Age | Median (range): 65 (48–78) years |
| Number of Prior Systemic Therapies | Median: null |
| Performance Status: ECOG | 0 — 1 1 — 6 2 — 0 3 — 0 Unknown — 0 |
| Cancer Types or Histologic Subtypes | Squamous cell carcinoma of head and neck, 4 Gastric/gastroesophageal adenocarcinoma, 1 Non-small cell lung cancer, 1 Urothelial cancer, 1 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
